Page last updated: 2024-11-04

vorinostat and Pulmonary Fibrosis

vorinostat has been researched along with Pulmonary Fibrosis in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.

Research Excerpts

ExcerptRelevanceReference
"Idiopathic pulmonary fibrosis (IPF) is a deadly disease characterized by chronic inflammation and excessive collagen accumulation in the lung."1.39Histone deacetylase inhibition downregulates collagen 3A1 in fibrotic lung fibroblasts. ( Hock, T; Liu, H; Sanders, YY; Thannickal, VJ; Zhang, X, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, X1
Liu, H1
Hock, T1
Thannickal, VJ1
Sanders, YY1

Other Studies

1 other study available for vorinostat and Pulmonary Fibrosis

ArticleYear
Histone deacetylase inhibition downregulates collagen 3A1 in fibrotic lung fibroblasts.
    International journal of molecular sciences, 2013, Sep-27, Volume: 14, Issue:10

    Topics: Animals; Cells, Cultured; Chromatin; Collagen Type III; Down-Regulation; Fibroblasts; Histone Deacet

2013